Factors relating to the cardiac sequelae of Kawasaki disease one month after initial onset

Acta Paediatrica, International Journal of Paediatrics

Volumn 91, Issue 5, 2002, Pages 517-520

  Zhang, T ^a   Yanagawa, H ^a   Oki, I ^a   Nakamura, Y ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Cardiac sequelae; Gamma globulin; Japan; Kawasaki disease; Neutrophil leucocyte

Indexed keywords

GLOBIN; IMMUNOGLOBULIN;

AGE; ARTICLE; DOSE RESPONSE; FEMALE; HEART DISEASE; HEMATOCRIT; HOSPITALIZATION; HUMAN; INFANT; LEUKOCYTE COUNT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PREDICTION AND FORECASTING; PRESCHOOL CHILD; RISK FACTOR; SEX DIFFERENCE; TIME; DRUG MEGADOSE; GENDER; JAPAN; MAJOR CLINICAL STUDY; NEUTROPHIL; NEWBORN; ONSET AGE; PREDICTION; PRIORITY JOURNAL;

AGE FACTORS; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLOBINS; HEART DISEASES; HEMATOCRIT; HUMANS; INFANT; LEUKOCYTE COUNT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIME FACTORS; HUMAN;

EID: 0036269419     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/080352502753711623     Document Type: Article

References (18)

1. Long-term consequences of Kawasaki disease: A 10- to 20-year follow-up study of 594 patients
2. Detection and management of cardiac involvement in the Kawasaki syndrome
3. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan
4. Kawasaki disease in infants less than one year of age
5. Cardiac sequelae in recurrent cases of Kawasaki disease: A comparison between the initial episode of the disease and a recurrence in the same patients
6. Effects of gamma globulin on the cardiac sequelae of Kawasaki disease
7. Factors related to cardiac sequelae of Kawasaki disease
8. The treatment of Kawasaki syndrome wilh intravenous gamma globulin
9. High dose intravenous gamma globulin for Kawasaki disease
10. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome
11. Selective high dose gamma-globulin treatment in Kawasaki disease: Assessment of clinical aspects and cost effectiveness
12. Early reactive neutrophil leukocyte change in an infant with Kawasaki syndrome
13. Prediction score for the CAL in the patient with Kawasaki disease in the 3-5 days after the first intravenous administration of gamma globulin
14. Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: Risk factors and role of aspirin
15. High-dose intravenous gamma globulin treatment of Kawasaki disease
16. Multicenter randomized controlled study of intravenous immunoglobulin G (c-425) for Kawasaki disease (2) Assessment for a change of neutrophil leukocyte count under immunoglobulin G therapy as a predictive factor for coronary artery lesions
17. Change of leukocyte counts in children with Kawasaki disease under different treatments
18. Leukocyte counts in patients with Kawasaki disease: From the results of nationwide survey of Kawasaki disease in Japan